Kura Oncology reported new preclinical diabetes data on its next-generation menin inhibitor, developed with Caspian Therapeutics. The findings were presented at EASD, highlighting Kura’s effort to expand beyond oncology.
published
Kura Oncology reported new preclinical diabetes data on its next-generation menin inhibitor, developed with Caspian Therapeutics. The findings were presented at EASD, highlighting Kura’s effort to expand beyond oncology.
Latest documented BWB result
$ASML market result
Exit $ASML with $5 profit per contract on the CDS
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.